• 14C custom radiolabelling, specialising in 14C GMP API, for metabolism, environmental fate and human ADME studies.
  • Structural elucidation and impurity profiling; synthesis and GLP characterisation of process impurity, degradation products and metabolites.
  • Unique peptidyl prolyl isomerase (PPIase) screening platform including binding and functional assays.
  • Providing integrated drug discovery services to pharma, biotechnology companies and academic institutions.

Drug Discovery

Providing integrated drug discovery services to pharma, biotechnology companies and academic institutions.

Read more

Medicinal Chemistry
Assay Development and Screening
Target Class and Disease Expertise

Radiolabelling

14C custom radiolabelling for metabolism, environmental fate and specialising in 14C GMP API for human ADME studies.

Read more

14C Custom Synthesis
14C GMP Radiolabelled API for Clinical Trials
GLP Analytics

Chemistry & Analytics

Structural elucidation and impurity profiling; synthesis and GLP characterisation of process impurity, degradation products and metabolites.

Read more

Custom Synthesis
Crop Science Expertise
GLP anaysis including GLP NMR

News

25 May 2016
Selcia opens new state-of-the-art API radiolabelling laboratory
29 February 2016
Selcia Celebrates Anniversary of the Discovery of Carbon-14

Upcoming Events

22 May 2016 to 26 May 2016
Discuss radiolabelling with our technical expert at the SETAC Europe Annual Meeting in Nantes
13 June 2016 to 16 June 2016
Selcia is attending the International Society for the Study of Xenobiotics meeting in South Korea.

Selcia Tweets